PetIQ, Inc. (PETQ) Given Consensus Rating of “Buy” by Analysts
Shares of PetIQ, Inc. (NASDAQ:PETQ) have been given an average recommendation of “Buy” by the six analysts that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $27.00.
Several research firms recently issued reports on PETQ. CIBC initiated coverage on PetIQ in a research note on Tuesday, August 15th. They issued an “outperform” rating and a $28.00 target price on the stock. Raymond James Financial, Inc. began coverage on PetIQ in a research report on Tuesday, August 15th. They set an “outperform” rating and a $26.00 price target for the company. Jefferies Group LLC began coverage on PetIQ in a report on Tuesday, August 15th. They issued a “hold” rating and a $25.00 price objective for the company. William Blair began coverage on PetIQ in a research report on Tuesday, August 15th. They issued an “outperform” rating on the stock. Finally, Oppenheimer Holdings, Inc. began coverage on PetIQ in a research report on Tuesday, August 15th. They issued an “outperform” rating and a $28.00 price objective on the stock.
Shares of PetIQ (NASDAQ PETQ) traded up 1.92% during mid-day trading on Wednesday, hitting $26.50. 121,741 shares of the stock traded hands. The firm’s 50-day moving average is $24.89 and its 200-day moving average is $26.13. The stock’s market cap is $350.41 million. PetIQ has a 52 week low of $19.76 and a 52 week high of $28.23.
PetIQ Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Receive News & Ratings for PetIQ Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ Inc. and related companies with MarketBeat.com's FREE daily email newsletter.